Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,815 across all filing types
Latest filing 2025-03-31 Transaction in Own Shar…
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2025
Transaction in Own Shares Classification · 1% confidence The document is explicitly titled "Transactions in connection with share buy-back program" and details the number of shares repurchased daily under a previously announced program, including transaction dates, volumes, and prices. This directly relates to the company managing its own stock, which falls under the definition of 'Transaction in Own Shares'. The document is a formal company announcement detailing these specific transactions, not just a general regulatory filing or an announcement of a report.
2025-03-31 English
Director's Dealing 2025
Director's Dealing Classification · 1% confidence The document consists entirely of tables detailing individual stock transactions (Issuer: GENMAB A/S, Date, Time, Quantity, Price, Venue) occurring on March 26, 2025. This format strongly indicates a report of insider trading or director/executive share transactions. Reviewing the definitions, 'Director's Dealing (Code: DIRS)' is the most appropriate classification for reports detailing personal share transactions by company directors and executives. The document is extensive (over 2 million characters), confirming it is the report itself, not just an announcement (RPA/RNS).
2025-03-31 English
Transaction in Own Shares 2025
Transaction in Own Shares Classification · 1% confidence The document is titled "Transactions in connection with share buy-back program" and details the number of shares repurchased daily, the average price, and the total value, explicitly referencing a share buy-back program initiated on March 25, 2025. This activity directly relates to the company managing its own stock, which corresponds to the definition of 'Transaction in Own Shares'. The filing type code for this activity is POS. The document is a detailed announcement, not just a notice that a report is attached, so RPA/RNS is not the primary classification.
2025-03-31 English
6-K
Foreign Filer Report
2025-03-25 English
Transaction in Own Shares 2025
Transaction in Own Shares Classification · 1% confidence The document is titled "Genmab Announces Initiation of Share Buy-Back Program" and details the terms, timeframe, and regulatory basis (MAR, Safe Harbour Regulation) for repurchasing up to 2.2 million shares. This action directly relates to the company's capital structure management and share transactions. The filing category 'Transaction in Own Shares' (POS) is specifically defined for reports of the company buying back or selling its own shares. Although it is an announcement, the core subject matter is the share repurchase itself, making POS a more precise fit than the general 'Report Publication Announcement' (RPA) or 'Regulatory Filing' (RNS). The document length (8076 chars) is substantial enough to be the primary announcement rather than just a brief notice pointing to an attachment, although an attachment link is present.
2025-03-25 English
Transaction in Own Shares 2025
Transaction in Own Shares Classification · 1% confidence The document is titled "Genmab Announces Initiation of Share Buy-Back Program" and details the terms, timeframe, and regulatory basis (MAR, Safe Harbour Regulation) for repurchasing up to 2.2 million shares. This action directly relates to the company managing its own stock and capital structure. Based on the provided definitions, the category "Transaction in Own Shares (Code: POS)" is the most accurate fit, as it covers the company buying back its own shares. While it is a financing activity, POS is more specific than CAP. It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K).
2025-03-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.